Toggle Nav
Close
  • Menu
  • Setting

Recombinant Human IL-19 (His, Strep)

Catalog No.
PH1027
Recombinant Human IL-19
Grouped product items
SizePriceStock Qty
10ug
$121.00
In stock
100ug
$608.00
In stock
500ug
$1,643.00
In stock
1mg
$2,629.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Interleukin-19 (IL-19) is a member of the IL-10 family of related cytokines. Its gene contains two alternate translation initiation sites, generating precursors of 215 amino acids (aa) and 177 aa, respectively. Both isoforms are processed to 17 kDa, 153 aa mature molecules. IL-19 contains seven helices and is secreted as a 35 kDa monomer. There are two potential N-linked glycosylation sites, and it is likely that the molecule is glycosylated. Mature human IL-19 shares 69% aa sequence identity with the mature mouse homologue. Although mouse IL-19 is active on human cells, human IL-19 is not active on mouse cells. IL-19 expression is limited to activated keratinocytes and monocytes. IL-19 binds a receptor complex consisting of the IL-20 receptor alpha (IL-20 R alpha, also known as IL-20 R1) and the IL-20 receptor beta (IL-20 R beta or IL-20 R2). This receptor complex is also shared by IL-20 and IL-24. Functionally, IL-19 induces IL-6 and TNF-alpha production by monocytes, and drives T-helper cell differentiation towards a Th2 response [1–5].
Reference
[1]. Gallagher, G. et al. (2000) Genes Immun. 1:442.
[2]. Gallagher, G. et al. (2004) Int. Immunopharmacol. 4:615.
[3]. Laio, Y-C. et al. (2002) J. Immunol. 169:4288.
[4]. Romer, J. et al. (2003) J. Invest. Dermatol. 121:1306.
[5]. Pestka, S. et al. (2004) Annu. Rev. Immunol. 22:929.

Information

Gene ID29949
Accession # Q9UHD0
Alternate NamesHuman IL19; interleukin-19; IL19; IL-19; melanoma differentiation associated protein-like protein
SourceHEK293
Protein sequenceLRRCLISTDMHHIEESFQEIKRAIQAKDTFPNVTILSTLETLQIIKPLDVCCVTKNLLAFYVDRVFKDHQEPNPKILRKISSIANSFLYMQKTLRQCQEQRQCHCRQEATNATRVIHDNYDQLEVHAAAIKSLGELDVFLAWINKNHEVMFSA
M.WtThe protein has a calculated MW of 20.4 kDa.
AppearanceSolution protein
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles - 36 months from date of receipt, -20 to -70°C as supplied
Concentration1 mg/mL
FormulationSupplied as a 0.2 μm filtered solution in PBS, pH7.4.
ReconstitutionWe recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. This solution can be diluted into other aqueous buffers.
Biological ActivityFully biologically active as determined by a cell proliferation assay using BaF3 mouse pro‑B cells transfected with human IL-20 Rα and human IL-20 Rβ cells. The EC50 for this effect is 4.8 ng/mL.
Shipping ConditionShipping with dry ice.
HandlingCentrifuge the vial prior to opening.
UsageFor Research Use Only! Not to be used in humans.

Quality Control

Quality Control & DataSheet

View current batch:
    Purity > 95 % by SDS-PAGE
    Endotoxin: Less than 1.0 EU/µg as determined by LAL method.
  • Datasheet